NEW YORK--(BUSINESS WIRE)--Bristol-Myers
Squibb Company (NYSE:BMY) will announce results for the fourth
quarter of 2018 on Thursday, January 24, 2019. During a conference call
at 10:30 a.m. ET on January 24, company executives will review financial
information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast
of the call at http://investor.bms.com
or by dialing in the U.S. toll free 800-458-4121 or international
786-789-4772, confirmation code: 9368504. Materials related to the call
will be available at the same website prior to the conference call. A
replay of the call will be available beginning at 1:45 p.m. ET on
January 24 through 1:45 p.m. ET on February 7, 2019. The replay will
also be available through http://investor.bms.com
or by dialing in the U.S. toll free 888-203-1112 or international
719-457-0820, confirmation code: 9368504.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Company Media: Carrie Fernandez609-252-5222 carrie.fernandez@bms.com Investors: John Elicker609-252-4611 john.elicker@bms.com Tim Power609-252-7509 timothy.power@bms.com Bill Szablewski609-252-5894 william.szablewski@bms.com